Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29650363

Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2018 May
First author
Cats A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 May;19(5):581-583. doi: 10.1016/S1470-2045(18)30153-0.
    note
    Source null
    related pmid
    29650361
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 Jul;19(7):e328. doi: 10.1016/S1470-2045(18)30369-3.
    note
    Source null
    related pmid
    30084371
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2018 Jul;19(7):e329. doi: 10.1016/S1470-2045(18)30366-8.
    note
    Source null
    related pmid
    30084372
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2018 Jul;19(7):e330. doi: 10.1016/S1470-2045(18)30381-4.
    note
    Source null
    related pmid
    30084373
    relationship
    Comment in
  5. citation
    Lancet Oncol. 2018 Jul;19(7):e331. doi: 10.1016/S1470-2045(18)30436-4.
    note
    Source null
    related pmid
    30084374
    relationship
    Comment in
  6. citation
    Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):233-242. doi: 10.1016/j.ijrobp.2018.05.026.
    note
    Source null
    related pmid
    30191854
    relationship
    Comment in
  7. citation
    Strahlenther Onkol. 2019 Jan;195(1):86-89. doi: 10.1007/s00066-018-1394-z.
    note
    Source null
    related pmid
    30374591
    relationship
    Comment in

Authors and identifiers

  1. name
    Cats A
    type
    Author
  2. name
    Jansen EPM
    type
    Author
  3. name
    van Grieken NCT
    type
    Author
  4. name
    Sikorska K
    type
    Author
  5. name
    Lind P
    type
    Author
  6. name
    Nordsmark M
    type
    Author
  7. name
    Meershoek-Klein Kranenbarg E
    type
    Author
  8. name
    Boot H
    type
    Author
  9. name
    Trip AK
    type
    Author
  10. name
    Swellengrebel HAM
    type
    Author
  11. name
    van Laarhoven HWM
    type
    Author
  12. name
    Putter H
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Cats A
    type
    Author
  2. name
    Jansen EPM
    type
    Author
  3. name
    van Grieken NCT
    type
    Author
  4. name
    Sikorska K
    type
    Author
  5. name
    Lind P
    type
    Author
  6. name
    Nordsmark M
    type
    Author
  7. name
    Meershoek-Klein Kranenbarg E
    type
    Author
  8. name
    Boot H
    type
    Author
  9. name
    Trip AK
    type
    Author
  10. name
    Swellengrebel HAM
    type
    Author
  11. name
    van Laarhoven HWM
    type
    Author
  12. name
    Putter H
    type
    Author
bibliography ids
  1. nci-bib-6d5ceae0ec2dd4cad1f83af4
book metadata
content sha256
e042cf2861afd4afe175a2a08c94aa9303ae73a52f52329d732e0584beebc417
document type
citation
dois
  1. 10.1016/S1470-2045(18)30132-3
electronic publication date
display
2018 Apr 9
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29650363
immutable id
pubmed:29650363@e042cf2861afd4afe175a2a08c94aa9303ae73a52f52329d732e0584beebc417
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
5
name
The Lancet. Oncology
nlm unique id
100957246
pages
616-628
volume
19
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 May;19(5):581-583. doi: 10.1016/S1470-2045(18)30153-0.
    note
    Source null
    related pmid
    29650361
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2018 Jul;19(7):e328. doi: 10.1016/S1470-2045(18)30369-3.
    note
    Source null
    related pmid
    30084371
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2018 Jul;19(7):e329. doi: 10.1016/S1470-2045(18)30366-8.
    note
    Source null
    related pmid
    30084372
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2018 Jul;19(7):e330. doi: 10.1016/S1470-2045(18)30381-4.
    note
    Source null
    related pmid
    30084373
    relationship
    Comment in
  5. citation
    Lancet Oncol. 2018 Jul;19(7):e331. doi: 10.1016/S1470-2045(18)30436-4.
    note
    Source null
    related pmid
    30084374
    relationship
    Comment in
  6. citation
    Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):233-242. doi: 10.1016/j.ijrobp.2018.05.026.
    note
    Source null
    related pmid
    30191854
    relationship
    Comment in
  7. citation
    Strahlenther Onkol. 2019 Jan;195(1):86-89. doi: 10.1007/s00066-018-1394-z.
    note
    Source null
    related pmid
    30374591
    relationship
    Comment in
outcomes validated
false
pmid
29650363
provenance
batch id
c4c0356d060413f719c2
provider
NCBI PubMed ESummary
record sha256
dcdc52bd7651e6447b0df13899fbbaf3f11dfda6a8cfb23596147b1cae9736b2
response sha256
adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
retrieved at
2026-09-09T23:47:33.674758+00:00
publication date
display
2018 May
precision
month
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29650363/
title
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.

Preserved source evidence · Not medical advice